Assessment of the Efficacy of Hemodialysis on Uric Acid Clearance at End Stage Kidney Disease in Sohag University Hospital

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: Uricemia dramatically rises with the stage of chronic kidney disease (CKD) and correlates with its mortality. Hemodialysis (HD) being the most used treatment at the end stage kidney disease in Sohag governorate , we sought to evaluate its efficacy on the clearance of uric acid (UAc) when used alone and twice per week.

Methods: A cross-sectional study of all consenting patients with CKD stage 5 recruited at random during hemodialysis sessions at hemodialysis unit in Sohag university hospital from July to December 2025. We collected socio-demographic data, relevant clinical information, hemodialysis related variables, and measured serum uric acid (SUA) levels before and after the dialysis to assess the uric acid clearance. A clearance between 65 and 80% and above 80% was considered as low and good efficacy of hemodialysis respectively

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• We included all consenting adults aged 18 or older, on maintenance hemodialysis for at least 3 consecutive months receiving 2 to 3 sessions weekly

Locations
Other Locations
Egypt
Sohag university faculty of medicine
RECRUITING
Sohag
Contact Information
Primary
Reham Hussien, master
rehamhussien1937@yahoo.com
00201092162739
Backup
Ali taha, Professor
00201005871047
Time Frame
Start Date: 2025-07-13
Estimated Completion Date: 2026-02-01
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Sohag University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials